Here’s an interview with a psychiatry resident on psychedelic research, where it’s going, where it’s been.
Read moreMore on Psychedelic Research
Johns Hopkins center is bringing renewed rigor to the investigation of the drugs’ therapeutic uses. Here’s an update.
Read moreKetamine for Depression
Here’s a look at the current research on ketamine for depression and mood disorders.
Read moreThe Future of Psychedelics
Here’s a look at what the future of psychedelic science holds.
Read moreResearch on 5-MeO-DMT
In addition to reducing symptoms of depression, the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) appears to cause changes in inflammatory biomarkers.
Read moreLSD and Alzheimer's
Microdosing LSD for Alzheimer’s proves safe in early human trial.
Read moreSilicon Valley's Wonder Drug?
Hmmm. A new startup called MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.
What do you think?
Read moreTop Ten Psychedelic Moments of 2019
Check out this recap of the top ten psychedelic moments of 2019!
Read morePsychedelics in the News
60 Minutes recently did a segment on psychedelics and how they can help with anxiety and addiction.
Read moreDMT and Consciousness
A new study shows that DMT creates a waking dream state in the brain and has remarkable effects in human consciousness.
Read moreResearch Updates
Here are some updates of what’s being researched in psychedelic therapy and treatment.
Read more